Class action filed against Boston Scientific over alleged misleading revenue projections.

A class action lawsuit has been filed against Boston Scientific Corporation for allegedly misleading investors about its revenue outlook and growth potential between July 23, 2025, and February 3, 2026. The complaint claims the company falsely portrayed confidence in its projected revenue and minimized risks from market competition and economic factors. After disappointing sales results and lowered guidance were announced on February 4, 2026, Boston Scientific's stock price dropped over 17%. Shareholders may participate in the lawsuit or serve as lead plaintiff by May 4, 2026.